Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index

Published:2017-06-20 Issue:6 Volume:33 Page:e2897
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Bonadonna Riccardo C.¹^ORCID,Blonde Lawrence²,Antsiferov Mikhail³,Berria Rachele⁴,Gourdy Pierre⁵,Hatunic Mensud⁶,Mohan Viswanathan⁷,Horowitz Michael⁸

Affiliation:

1. University of Parma and Azienda Ospedaliero-Universitaria di Parma; Parma Italy

2. Frank Riddick Diabetes Institute; Department of Endocrinology, Ochsner Medical Center; New Orleans LA USA

3. Moscow Department of Health Care; Moscow Russian Federation

4. Sanofi; Bridgewater NJ USA

5. Diabetology Department; Toulouse University Hospital; Toulouse France

6. Department of Endocrinology; Mater Misericordiae University Hospital; Dublin Ireland

7. Madras Diabetes Research Foundation & Dr Mohan's Diabetes Specialities Centre; Chennai India

8. Royal Adelaide Hospital; Adelaide Australia

Funder

This study was sponsored by Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.2897/fullpdf

Reference50 articles.

1. Dysfunction of retinal neurons and glia during diabetes;Fletcher;Clin Exp Optom,2005

2. Diabetes, hyperglycaemia, and acute ischaemic stroke;Luitse;Lancet Neurol,2012

3. Associations between structural and functional changes to the kidney in diabetic humans and mice;Powell;Life Sci,2013

4. Hyperglycaemia, diabetes and myocardial infarction;Yudkin;Diabet Med,1987

5. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c);Monnier;Diabetes Care,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

2. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22

3. Distinct hypoglycemic effect of different formulations of a fixed ratio of basal insulin plus glucagon-like peptide-1 receptor agonist in a patient with pancreatic diabetes;Diabetology International;2023-04-10

4. C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective;Diabetes, Obesity and Metabolism;2022-06-28

5. Effects of L‐arabinose by hypoglycemic and modulating gut microbiome in a high‐fat diet‐ and streptozotocin‐induced mouse model of type 2 diabetes mellitus;Journal of Food Biochemistry;2021-11-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3